TEKTROTYD

This brand name is authorized in Estonia, Spain, France, Malta, Poland, Romania

Active ingredients

The drug TEKTROTYD contains one active pharmaceutical ingredient (API):

1 Technetium ⁹⁹ᵐTc hynic-octreotide

Technetium ⁹⁹ᵐTc hynic-octreotide is for diagnostic use only. Technetium (99mTc) labelled EDDA/HYNIC-TOC binds with high affinity to somatostatin receptor subtypes 2 and 5, also to subtype 3 but with lesser affinity.

Read about Technetium ⁹⁹ᵐTc hynic-octreotide

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
V09IA07 V Various → V09 Diagnostic radiopharmaceuticals → V09I Tumour detection → V09IA Technetium (99mTc) compounds
Discover more medicines within V09IA07

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: EE Ravimiamet Identifier(s): 1681680
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 80718
Country: FR Base de données publique des médicaments Identifier(s): 61249354
Country: MT Medicines Authority Identifier(s): MA1214/00301
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100138327, 100341488
Country: RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale Identifier(s): W63076001

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.